Log In
Print
BCIQ
Print
Print this Print this
 

AVI-7288

  Manage Alerts
Collapse Summary General Information
Company Sarepta Therapeutics Inc.
DescriptionSingle oligomer nucleic acid analog based on morpholino-modified phosphorodiamidate oligomers (PMO) antisense chemistry
Molecular Target
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPhase I
Standard IndicationViral infection
Indication DetailsTreat Marburg virus infection
Regulatory Designation

U.S. - Fast Track (Treat Marburg virus infection)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today